Key facts
- A bipartisan Senate bill has been introduced to reduce the United States' reliance on China for pharmaceuticals.
- The legislation aims to bolster domestic manufacturing and supply chains for critical drug components.
- The bill seeks to decrease dependence on China in the pharmaceutical industry.
A bipartisan bill has been introduced in the Senate with the objective of reducing the United States' dependence on China for pharmaceuticals and essential drug components. The proposed legislation is designed to strengthen domestic manufacturing capabilities and enhance the resilience of the pharmaceutical supply chain.